rituximab

https://www.youcanknowthings.com/how-one-neuroscientist-solved-the-mystery-of-his-own-long-covid-2/ Interesting article, sadly few have access to this level of testing Ritixumab being used

research from Singapore… @Jonathan Edwards? paywall for me. https://www.jni-journal.com/article/S0165-5728(25)00039-6/abstract Efficacy of rituximab on antibody-positive small fiber neuropathy: A series of 5 cases Results Two patients were positive for anti-TS-HDS, one for anti-plexin D1...

HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab Eva Martín-Martínez, Sara Gil-Perotin, Karen Giménez-Orenga, Lucas Barea-Moya, Elisa Oltra [Line breaks added] Abstract This article summarizes the case of 30-year-old male diagnosed with...

Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment Maike Gallwitz, Isa Lindqvist, Jan Mulder, Annica J Rasmusson, Anders Larsson, Evelina Husén, Jesper Borin, Peter J van der Spek, Nour Sabbagh, Anna Widgren, Jonas...

Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy Anne Louise Oaklander, Julia Allen, Nadja Dietliker, Einar P. Wilder-Smith OBJECTIVES To expand understanding of the pathogenesis, presentations, and treatment of initially idiopathic small fiber polyneuropathy (SFN). METHODS...

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Ingrid G. Rekeland; Kari Sørland; Lisbeth Lykke Neteland; Alexander Fosså; Kine Alme; Kristin Risa; Olav Dahl; Karl J. Tronstad; Olav Mella; Øystein...

Hi all Ive just been reading about Rituximab within the context of autoimmune disease. Im aware of the CD20 and plasma (antibody generating) split within cells, but that for a lot of autoimmune diseases there is clinical response and patient symptom relief. We all know about the failed Ritux...

https://bora.uib.no/bora-xmlui/handle/11250/3127770 Source: University of Bergen Date: May 2, 2024 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Clinical trials, medical treatment and pathomechanisms ------------------------------------------------------------ Ingrid Gurvin...

Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study Venkat, Rathnam K; Wang, Xiaosong; Patel, Naomi J; Kawano, Yumeko; Schiff, Abigail; Kowalski, Emily N; Cook, Claire E; Vanni, Kathleen M M; Qian, Grace; Bade...

Hi all, its appears a German Dr, Dr Habets who is an Oncologist, is undertaking a trial (or just randomly treating its very hard to tell) with Rituximab in Long COVID and Me/cfs patients who test positive for GCPR aabs via bioassay (ie not ELISA). Its REALLY hard to fully understand what is...

Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2 Highlights Persistence of SARS-CoV-2 infection among immunocompromised patients are due to inability of the immune system to eliminate the virus...

A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients Parkes, Joanna E; Boehler, Jessica F; Li, Ning; Kendra, Ryan M; O’Hanlon, Terrance P; Hoffman, Eric P; Peterson, Jennifer M; Miller, Frederick W; Rider, Lisa G...

https://www.theguardian.com/science/2020/oct/25/the-dementia-that-can-be-cured The dementia that can be cured Treatments mentioned include steroids, rituximab and plasma exchange.

'Skeptic Doc' Harriet A. Hall MD has just published a new blog post about the use of Rituximab for ME/CFS. https://www.skepdoc.info/chronic-fatigue-syndrome-and-rituximab/

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SUMMARY: Could the positive results of the early Fluge & Mella 2011 blinded phase II rituximab trial and 2015 open label phase II study be due to inadvertently including some Giardia lamblia ME/CFS patients in the cohort, from the 2004 Bergen Giardia...

Paywalled at https://www.clinicaltherapeutics.com/article/S0149-2918(19)30112-2/fulltext

B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial https://annals.org/aim/article-abstract/2729813/b-lymphocyte-depletion-patients-myalgic-encephalomyelitis-chronic-fatigue-syndrome-randomized...

Rituximab Serum Concentrations and Anti- Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome Rekeland, Fluge, Mella et al (only the abstract is available for now) Findings There were no significant differences in mean serum rituximab...

I think this is new: http://www.investinme.org/IIMER-Newslet-1802-01.shtml February 2018 Rituximab Trial and Research Statement Following Preliminary Phase III Rituximab Clinical trial Results from Norway Following the preliminary results which Professor Olav Mella recently publicly released...

by Amy Maxmen Very long article that speaks about Dr Jose Montoya, Dr Anthony Komaroff, Dr Leonard Jason, the Rituximab trial, Dr Derya Unutmaz, the NIH program, Dr Ron Davis and David Tuller https://www.nature.com/articles/d41586-017-08965-0?WT.feed_name=subjects_biotechnology Edit: Amy...